Rupert Conrad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rupert Conrad has a total of 185 co-authors. Here are the top co-authors by number of shared publications:
Franziska Geiser
Department of Psychosomatic Medicine and Psychotherapy, University of Bonn, Bonn, Germany
11 shared publicationsIngo Wegener
Department of Psychosomatic Medicine and Psychotherapy, University of Bonn, Bonn, Germany
8 shared publicationsKatrin Imbierowicz
Department of Psychosomatic Medicine and Psychotherapy, University of Bonn, Germany
6 shared publicationsReinhard Liedtke
Department of Psychosomatic Medicine and Psychotherapy, University of Bonn, Germany
6 shared publicationsBerndt Zur
Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany
4 shared publicationsAlexandra Kleiman
Department of Psychosomatic Medicine and Psychotherapy, University of Bonn, Bonn, Germany
3 shared publications
Latest Publications
- Open Access
Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling
The major anxiety disorders (ANX; including generalized anxiety disorder, panic disorder, and phobias ) are highly prevalent, often onset early, persist throughout life, and cause substantial global disability. Although distinct in their clinical presentations, they likely represent differential expressions of a dysregulated threat-response system. Here we present a genome-wide association meta-analysis comprising 122,341 European ancestry ANX cases and 729,881 controls. We identified 58 independent genome-wide significant ANX risk variants and 66 genes with robust biological support. In an independent sample of 1,175,012 self-report ANX cases and 1,956,379 controls, 51 of the 58 associated variants were replicated. As predicted by twin studies, we found substantial genetic correlation between ANX and depression, neuroticism, and other internalizing phenotypes. Follow-up analyses demonstrated enrichment in all major brain regions and highlighted GABAergic signaling as one potential mechanism underlying ANX genetic risk. These results advance our understanding of the genetic architecture of ANX and prioritize genes for functional follow-up studies.
Open AccessGenome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling
The major anxiety disorders (ANX; including generalized anxiety disorder, panic disorder, and phobias ) are highly prevalent, often onset early, persist throughout life, and cause substantial global disability. Although distinct in their clinical presentations, they likely represent differential expressions of a dysregulated threat-response system. Here we present a genome-wide association meta-analysis comprising 122,341 European ancestry ANX cases and 729,881 controls. We identified 58 independent genome-wide significant ANX risk variants and 66 genes with robust biological support. In an independent sample of 1,175,012 self-report ANX cases and 1,956,379 controls, 51 of the 58 associated variants were replicated. As predicted by twin studies, we found substantial genetic correlation between ANX and depression, neuroticism, and other internalizing phenotypes. Follow-up analyses demonstrated enrichment in all major brain regions and highlighted GABAergic signaling as one potential mechanism underlying ANX genetic risk. These results advance our understanding of the genetic architecture of ANX and prioritize genes for functional follow-up studies.
- 12 September 2017
- Published by Springer Nature
- p. 171-189
Flucht und Trauma – Psychische Implikationen der Heimatlosigkeit
- 12 September 2017
- Published by Springer Nature
- p. 171-189
Flucht und Trauma – Psychische Implikationen der Heimatlosigkeit
- 1 June 2017
- Published by Wolters Kluwer Health in Psychiatric Genetics
- Vol. 27 (3) , 96-102
Further evidence for genetic variation at the serotonin transporter gene SLC6A4 contributing toward anxiety
Social anxiety disorder (SAD) is a common and heritable psychiatric disorder. However, genetic studies in SAD are rare and only a few candidate genes have been implicated so far. In the present study, we investigated whether single-nucleotide polymorphisms (SNPs) associated with other psychiatric disorders also contribute toward the development of SAD and followed up variants associated with SAD on the phenotypic level. We genotyped a total of 24 SNPs in a German sample of 321 SAD patients and 804 controls. We carried out single-marker analyses as well as quantitative association analyses of SAD severity and harm avoidance. None of the variants investigated showed an association with SAD in our case–control sample after Bonferroni correction. Two SNPs reached nominal significance (rs818702, P=0.032; rs140701, P=0.048). Of these, only rs140701 showed an association in the same allelic direction as reported previously. This SNP is located within the serotonin transporter gene SLC6A4, which is the primary target of selective-serotonin reuptake inhibitors used for the treatment of depressive and anxiety disorders. The quantitative association analysis of all cases with available data on symptom severity showed four SNPs with a nominal significant association. Among these SNPs, rs10994359 showed the strongest association (P=0.001) and was located near the ANK3 gene. In addition, rs10994359 was nominally associated with harm avoidance scores (P=0.001). Our results provide further evidence for an involvement of the serotonin transporter gene SLC6A4 in the etiology of anxiety-related traits. Furthermore, our study implicates that genetic variation at the genome-wide associated bipolar disorder locus ANK3 might influence anxiety-related personality traits.
- 1 June 2017
- Published by Wolters Kluwer Health in Psychiatric Genetics
- Vol. 27 (3) , 96-102
Further evidence for genetic variation at the serotonin transporter gene SLC6A4 contributing toward anxiety
Social anxiety disorder (SAD) is a common and heritable psychiatric disorder. However, genetic studies in SAD are rare and only a few candidate genes have been implicated so far. In the present study, we investigated whether single-nucleotide polymorphisms (SNPs) associated with other psychiatric disorders also contribute toward the development of SAD and followed up variants associated with SAD on the phenotypic level. We genotyped a total of 24 SNPs in a German sample of 321 SAD patients and 804 controls. We carried out single-marker analyses as well as quantitative association analyses of SAD severity and harm avoidance. None of the variants investigated showed an association with SAD in our case–control sample after Bonferroni correction. Two SNPs reached nominal significance (rs818702, P=0.032; rs140701, P=0.048). Of these, only rs140701 showed an association in the same allelic direction as reported previously. This SNP is located within the serotonin transporter gene SLC6A4, which is the primary target of selective-serotonin reuptake inhibitors used for the treatment of depressive and anxiety disorders. The quantitative association analysis of all cases with available data on symptom severity showed four SNPs with a nominal significant association. Among these SNPs, rs10994359 showed the strongest association (P=0.001) and was located near the ANK3 gene. In addition, rs10994359 was nominally associated with harm avoidance scores (P=0.001). Our results provide further evidence for an involvement of the serotonin transporter gene SLC6A4 in the etiology of anxiety-related traits. Furthermore, our study implicates that genetic variation at the genome-wide associated bipolar disorder locus ANK3 might influence anxiety-related personality traits.
- Open Access
- 1 October 2016
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 9, 819-823
The hardest thing to see is what is in front of your eyes – quo vadis placebo analgesia?
The hardest thing to see is what is in front of your eyes â
- 1 October 2016
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 9, 819-823
Open AccessThe hardest thing to see is what is in front of your eyes – quo vadis placebo analgesia?
The hardest thing to see is what is in front of your eyes â
- 1 May 2016
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 67, 1-8
Psychosocial assessment of living kidney donors: What implications have temperament and character for decision-making?
- 1 May 2016
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 67, 1-8
Psychosocial assessment of living kidney donors: What implications have temperament and character for decision-making?
- 11 January 2016
- Published by Elsevier in Psychiatry Research
- Vol. 237, 316-322
Psychophysiological decoupling in alexithymic pain disorder patients
- 11 January 2016
- Published by Elsevier in Psychiatry Research
- Vol. 237, 316-322
Psychophysiological decoupling in alexithymic pain disorder patients
- 11 June 2015
- Published by Georg Thieme Verlag KG in PiD - Psychotherapie im Dialog
- Vol. 16 (02) , 44-47
Integration psychodynamischer und kognitiv-behavioraler Interventionen bei Panikstörung / Agoraphobie
In der Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie der Universität Bonn erhalten Patienten mit Panikstörung und Agoraphobie im Rahmen eines multimodalen Settings sowohl eine psychodynamische Einzel- und Gruppentherapie als auch eine angstspezifische Verhaltenstherapie im Einzelsetting und eine verhaltenstherapeutische Interaktionsübungsgruppe. Was sind die Hintergründe dafür, wie sieht die Umsetzung aus und wo liegen die Vorteile und Probleme der Kombination beider Therapieansätze?
- 11 June 2015
- Published by Georg Thieme Verlag KG in PiD - Psychotherapie im Dialog
- Vol. 16 (02) , 44-47
Integration psychodynamischer und kognitiv-behavioraler Interventionen bei Panikstörung / Agoraphobie
In der Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie der Universität Bonn erhalten Patienten mit Panikstörung und Agoraphobie im Rahmen eines multimodalen Settings sowohl eine psychodynamische Einzel- und Gruppentherapie als auch eine angstspezifische Verhaltenstherapie im Einzelsetting und eine verhaltenstherapeutische Interaktionsübungsgruppe. Was sind die Hintergründe dafür, wie sieht die Umsetzung aus und wo liegen die Vorteile und Probleme der Kombination beider Therapieansätze?
- 1 April 2015
- Published by Elsevier in Clinica Chimica Acta
- Vol. 444, 167-169
IgG subclass distribution in patients with monoclonal gammopathy
- 1 April 2015
- Published by Elsevier in Clinica Chimica Acta
- Vol. 444, 167-169
IgG subclass distribution in patients with monoclonal gammopathy
- 1 April 2015
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 108 (1) , 15-22
Impact of carbamylation on three different methods, HPLC, capillary electrophoresis and TINIA of measuring HbA1c levels in patients with kidney disease
- 1 April 2015
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 108 (1) , 15-22
Impact of carbamylation on three different methods, HPLC, capillary electrophoresis and TINIA of measuring HbA1c levels in patients with kidney disease
- 1 February 2015
- Published by Elsevier in Psychiatry Research
- Vol. 225 (3) , 355-363
Factorial structure of the 20-item Toronto Alexithymia Scale in a large sample of somatoform patients
- 1 February 2015
- Published by Elsevier in Psychiatry Research
- Vol. 225 (3) , 355-363
Factorial structure of the 20-item Toronto Alexithymia Scale in a large sample of somatoform patients